Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Return on Assets [ROA] (2016 - 2026)

Updated

Outlook Therapeutics' Return on Assets [ROA] came in at -214.44% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 183.11 percentage points from -397.55% a year earlier and up 41.63 percentage points from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Return on Assets [ROA] was -263.36%, down 16.75 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -72.19 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Assets [ROA] was -246.60% in FY2024 (-52.67 pp), -193.93% in FY2023 (+63.39 pp), -257.32% in FY2022 (-7.40 pp) and -249.92% in FY2021 (-58.75 pp).
  • The fiscal Q3 2026 figure represents the highest quarterly Return on Assets [ROA] since fiscal Q2 2025.
  • Year-over-year, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -71.35 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q2 2025 (a gain of 293.18 percentage points), and the weakest in fiscal Q2 2024 (a drop of 299.27 percentage points).
  • Business Quant data shows OTLK's Return on Assets [ROA] at -256.07% (Q2 2026), -506.68% (Q1 2026) and -494.97% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00 -214.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -214.44%
Mar 31, 2026 -256.07%
Dec 31, 2025 -506.68%
Sep 30, 2025 -495.21%
Jun 30, 2025 -397.79%
Mar 31, 2025 -99.29%
Dec 31, 2024 -374.63%
Sep 30, 2024 -195.81%
Jun 30, 2024 -175.28%
Mar 31, 2024 -391.73%
Dec 31, 2023 -186.92%
Sep 30, 2023 -152.33%
Jun 30, 2023 -121.48%
Mar 31, 2023 -97.12%
Dec 31, 2022 -152.88%
Sep 30, 2022 -193.97%
Jun 30, 2022 -120.73%
Mar 31, 2022 -80.36%
Dec 31, 2021 -102.88%
Sep 30, 2021 -190.54%
API Access

Outlook Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEY